Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
Saved in:
Main Authors: | Ahmed Donia, Ramla Shahid, Muhammad Nawaz, Tahir Yaqub, Habib Bokhari |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2ecd9f51bbf54eb393b7c8f7ccb6947e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenging clinical and organizational scenarios in cardiovascular diseases during the SARS-CoV-2 pandemic in Poland. Can we do better?
by: Wojciech Wojakowski, et al.
Published: (2020) -
COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review
by: Naz Sumaira, et al.
Published: (2021) -
How we prepared our operating theatre for patients with
SARS-CoV-2 virus
by: Justyna Rymarowicz, et al.
Published: (2020) -
Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic?
by: Arturo Casadevall, et al.
Published: (2021) -
Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
by: Phil-Robin Tepasse, et al.
Published: (2021)